Levin Capital Strategies, L.P. Pfizer Inc Call Options Transaction History

Levin Capital Strategies, L.P.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 06, 2024	BUY	$26.13 - $33.94 $104,520 - $135,760	4,000 New	4,000 $115,000
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $697,950 - $827,550	15,000 Added 300.0%	20,000 $1.05 Million
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $457,500 - $566,900	-10,000 Reduced 66.67%	5,000 $259,000
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $179,549 - $203,400	5,000 Added 50.0%	15,000 $587,000
Q1 2021 May 05, 2021	BUY	$33.49 - $37.77 $334,900 - $377,700	10,000 New	10,000 $362,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

Stay updated on Levin Capital Strategies, L.P. with notifications on news.